Exploration of novel 20S proteasome activators featuring anthraquinone structures and their application in hypoxic cardiomyocyte protection
Qian Yu(Union Hospital), Huajian Zhu(China Pharmaceutical University), Jiaan Shao(Zhejiang University), Yubo Zhou(Shanghai Institute of Materia Medica), Yubing Han(Shanghai Institute of Materia Medica), Linghui Zeng(Zhejiang University), Jianjun Xi(Hangzhou Xixi hospital), Jinxin Che(Zhejiang University of Technology), Chong Zhang(Nanjing University of Information Science and Technology), Lee Jia(Chengdu University of Traditional Chinese Medicine), Yizhou Xu(Westlake University), Jiankang Zhang(Westlake University), Lixin Gao(Shanghai Institute of Materia Medica), Yu Cao(Shanghai Institute of Materia Medica), Linhao Xu(Hangzhou First People's Hospital), Linjie Li(Ministry of Education of the People's Republic of China), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University), Liteng Shen(Chinese Academy of Sciences)
Cited by 1
Related Papers
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Methanotrophs: Multifunctional bacteria with promising applications in environmental bioengineering
|Biochemical Engineering Journal|2010|208
<p>Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT</p>
|OncoTargets and Therapy|2019|120